← Back to the feed

Micreos Pharmaceuticals AG

History from 14 Dec 2021

UID

CHE-430.397.336

Legal form

AG

Canton

ZG

Founded

14 Dec 2021

Amount raised

not in the SHAB

Lead investor

not in the SHAB

Record

1. SHAB published 17 Dec 2021 · legal date 14 Dec 2021

   Company formed

   Founded 14 Dec 2021

   SHAB HR01-1005360089 ↗

2. SHAB published 6 Oct 2025 · legal date 23 Sep 2025

   Capital increase

   ○○○Capital increased

   Paid by converting claims

   Nominal capital

   200’000 → 399’999.69

   Shares

   20’000’000 → 39’999’969

   New shares, % of post-step shares

   50.0% (19’999’969 new)

   Aktienkapital neu: CHF 399'999.69 [bisher: CHF 200'000.00]. Liberierung Aktienkapital neu: CHF 399'999.69 [bisher: CHF 200'000.00]. Aktien neu: 39'999'969 vinkulierte Namenaktien zu CHF 0.01 [bisher: 20'000'000 vinkulierte Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5
   • Paid entirely by converting existing claims, with no new money.−1.5

   Classifier score 0.22 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006450194 ↗

3. SHAB published 12 Feb 2026 · legal date 4 Feb 2026

   Capital increase

   ●●○Likely financing

   Paid in cash and by other means

   Nominal capital

   399’999.69 → 475’045.68

   Shares

   39’999’969 → 47’504’568

   New shares, % of post-step shares

   15.8% (7’504’599 new)

   Share classes

   39’999’969 × CHF 0.01 · 6’614’771 × CHF 0.01 Vorzugsaktien Class B1 · 889’828 × CHF 0.01 Vorzugsaktien Class B2

   Aktienkapital neu: CHF 475'045.68 [bisher: CHF 399'999.69]. Liberierung Aktienkapital neu: CHF 475'045.68 [bisher: CHF 399'999.69]. Aktien neu: 39'999'969 vinkulierte Namenaktien zu CHF 0.01, 6'614'771 vinkulierte Namenaktien zu CHF 0.01 (Vorzugsaktien Class B1) und 889'828 Namenaktien zu CHF 0.01 (Vorzugsaktien Class B2) [bisher: 39'999'969 vinkulierte Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung. Kapitalband gemäss näherer Umschreibung in den Statuten.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5
   • A new class of preferred shares was created.+1.5

   Classifier score 0.88 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006567792 ↗

4. SHAB published 12 Feb 2026 · legal date 4 Feb 2026

   Capital band adopted

   SHAB HR02-1006567792 ↗

5. SHAB published 5 Aug 2026 · legal date 27 Jul 2026

   Capital increase

   ●●○Likely financing

   Paid in cash and by other means

   Nominal capital

   475’045.68 → 518’497.64

   Shares

   47’504’568 → 51’849’764

   New shares, % of post-step shares

   8.4% (4’345’196 new)

   Share classes

   39’999’969 × CHF 0.01 · 9’180’309 × CHF 0.01 Vorzugsaktien Class B1 · 2’669’486 × CHF 0.01 Vorzugsaktien Class B2

   Aktienkapital neu: CHF 518'497.64 [bisher: CHF 475'045.68]. Liberierung Aktienkapital neu: CHF 518'497.64 [bisher: CHF 475'045.68]. Aktien neu: 39'999'969 vinkulierte Namenaktien zu CHF 0.01, 9'180'309 vinkulierte Namenaktien zu CHF 0.01 (Vorzugsaktien Class B1) und 2'669'486 vinkulierte Namenaktien zu CHF 0.01 (Vorzugsaktien Class B2) [bisher: 39'999'969 vinkulierte Namenaktien zu CHF 0.01, 889'828 Namenaktien zu CHF 0.01 (Vorzugsaktien Class B2) und 6'614'771 vinkulierte Namenaktien zu CHF 0.01 (Vorzugsaktien Class B1)]. Ordentliche Kapitalerhöhung innerhalb des Kapitalbandes.

   • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
   • The company was founded less than six years before this capital increase.+0.5
   • The company's purpose describes technology or life-sciences development.+0.5

   Classifier score 0.80 · likely-financing threshold 0.60 · not a calibrated probability

   SHAB HR02-1006724432 ↗

Published by 8 Oct 2026